Fidelity European Trust November Factsheet: Tech and financial gains

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for November 2024.

Portfolio Manager Commentary 

Continental European equities delivered negative returns in November. Early optimism around Donald Trump’s win in the US presidential election subsided, as investors shifted their focus towards the impact of potential US trade tariffs on the eurozone’s growth. Sentiment was also impacted by political instability in France and Germany.  

During the month, the Trust performed in line with the index. Security selection in financials and technology sectors contributed, while gearing added some value, although stock selection in industrials and energy detracted. The Trust’s holding in 3i group was the top contributor, with the group delivering particularly strong gains following the announcement of strong financial results for the first half of fiscal year 2025. In technology, the Trust’s holding in SAP continued to rise after the company reported third quarter earnings and revenue in October that slightly beat estimates and raised its outlook for cloud computing and software revenue. These gains were partially offset by the Trust’s exposure to Legrand. Shares declined following the underwhelming third quarter 2024 results, as sales fell short of consensus expectations, primarily due to softness in the European market.   

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. On a rolling 12-month basis, the Trust recorded NAV and share price returns of 6.9% and 4.6% respectively, compared to 8.2% for the index. 

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

European equities hold ground ahead of policy shifts

European equities edge up as investors navigate a week of policy signals and key data with deliberate caution.

European defence stocks climb on German procurement momentum

Germany’s military procurement plans have kicked defence stocks into motion, giving investors a clearer signal on where the capital is headed.

Fidelity European Trust rose in October with chipmaker ASML top contributor

Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas.

European stocks climb as legal reset reopens a long discounted risk

Legal momentum in the US reframes a long-discounted risk for Bayer, with ripple effects across European indices

Search

Search